Skip to content

APOTEEK SERMEUS

Active
Private limited company (pre-2019)founded 198640 yrs activeTervuursesteenweg 198, 1981 Zemst, BelgiumKBO/BCE: BE 0429.117.409

APOTEEK SERMEUS has been active since 1986 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.04M and a net result of €81k. Equity is growing by ~12.3% per year across the filed fiscal years. Its solvency ranks better than 71% of 10345 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
82 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability74▼-2
Solvency84▲+5
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €85k at 30 days acceptable
Liquidity ample (current ratio 3.31 against 3.17 in 2024; short-term debt: 12.1% and cash: 28% of total assets), and 41.4% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 40 years 0 50 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
58.6%
Return on assets
4.5%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 23-12-2025, 39 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
39 d early
2024
43 d early
2023
16 d early
2022
27 d early
2021
6 d early
2020
2 d early
2019
42 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close22-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€1.04M▲ 8.4%
2024 · €961k
2019: €470k 2020: €550k 2021: €657k 2022: €799k 2023: €905k 2024: €961k
2019 → 2025
Total assets
€1.78M▼ 0.7%
2024 · €1.79M
2019: €679k 2020: €1.15M 2021: €1.91M 2022: €2.03M 2023: €2.06M 2024: €1.79M
2019 → 2025
Net result
€81k▼ 23.9%
2024 · €106k
2019: €98k 2020: €87k 2021: €107k 2022: €142k 2023: €106k 2024: €106k
2019 → 2025
Working capital
€498k▲ 13.9%
2024 · €438k
2019: €463k 2020: €421k 2021: €427k 2022: €454k 2023: €430k 2024: €438k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€657k-€799k▲ 21.7%€905k▲ 13.2%€961k▲ 6.2%€1.04M▲ 8.4%
Operating result€138k-€221k▲ 60.8%€169k▼ 23.6%€165k▼ 2.3%€125k▼ 24.6%
Net result€107k-€142k▲ 33.2%€106k▼ 25.8%€106k▲ 0.3%€81k▼ 23.9%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2021: €138k€138kNet result 2021: €107k€107kOperating result 2022: €221k€221kNet result 2022: €142k€142kOperating result 2023: €169k€169kNet result 2023: €106k€106kOperating result 2024: €165k€165kNet result 2024: €106k€106kOperating result 2025: €125k€125kNet result 2025: €81k€81k20212022202320242025
The operating result has fallen three years in a row; 2025 is 25% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.78M
Fixed assets €1.06M▼ 7.6%
Current assets €714k▲ 11.7%
Equity and liabilities €1.78M
Equity €1.04M▲ 8.4%
Debt €735k▼ 11.2%
The debt ratio falls from 46.3% to 41.4%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€234k
2024 · €273k
Cash flow
€191k
2024 · €214k
Solvency
58.6%
2024 · 53.7%
Current ratio
3.31
2024 · 3.17
Quick ratio
2.77
2024 · 2.54
Debt / equity
0.71
2024 · 0.86
ROE
7.7%
2024 · 11.0%
ROA
4.5%
2024 · 5.9%
Interest coverage
19.36
2024 · 18.32
Debt
€735k
2024 · €828k
Debt ≤ 1 year
€216k
2024 · €202k
Debt > 1 year
€515k
2024 · €621k
Income taxes
€36k
2024 · €48k
Staff costs
€95k
2024 · €84k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.79M€1.78M
Fixed assets21/28€1.15M€1.06M
Tangible fixed assets22/27€1.15M€1.06M
Land and buildings22€692k€651k
Plant, machinery and equipment23€369k€335k
Furniture and vehicles24€43k€37k
Other tangible fixed assets26€47k€38k
Current assets29/58€639k€714k
Stocks and contracts in progress3€126k€116k
Stocks30/36€126k€116k
Amounts receivable within one year40/41€66k€87k
Trade receivables40€63k€71k
Other amounts receivable41€4k€16k
Current investments50/53€125k€5k
Cash at bank and in hand54/58€315k€498k
Deferred charges and accrued income490/1€7k€8k
Equity and liabilities
Total equity and liabilities10/49€1.79M€1.78M
Equity10/15€961k€1.04M
Contributions10/11€25k€25k=
Reserves13€898k€979k
Distributable reserves133€898k€979k
Profit (loss) carried forward14€38k€38k=
Amounts payable17/49€828k€735k
Amounts payable after more than one year17€621k€515k
Financial debts170/4€620k€515k
Other amounts payable178/9€100€100=
Amounts payable within one year42/48€202k€216k
Current portion of amounts payable after more than one year42€104k€105k
Trade debts44€42k€57k
Suppliers440/4€42k€57k
Taxes, remuneration and social security45€30k€20k
Taxes450/3€18k€9k
Remuneration and social security454/9€12k€10k
Other amounts payable47/48€25k€34k
Accrued charges and deferred income492/3€6k€4k
Income statement Code20242025
Remuneration, social security and pensions62€84k€95k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€108k€110k
Other operating charges640/8€6k€6k
Non-recurring operating charges66A-€1k
Gross operating margin9900€362k€337k
Operating profit (loss)9901€165k€125k
Financial income75/76B€3k€4k
Recurring financial income75€3k€4k
Financial charges65/66B€15k€12k
Recurring financial charges65€15k€12k
Profit (loss) for the period before taxes9903€154k€117k
Income taxes67/77€48k€36k
Profit (loss) for the period9904€106k€81k
Profit (loss) for the period to be appropriated9905€106k€81k
Appropriation of the result
Profit (loss) to be appropriated9906€144k€119k
Profit (loss) brought forward from the previous period14P€38k€38k=
Transfer from equity791/2€50k€0
Transfer to equity691/2€106k€81k
To other reserves6921€106k€81k
Profit to be distributed694/7€50k€0
Return on contributions (dividend)694€50k€0
Social balance
Average headcount (FTE)90871.71.9

The notes to these accounts (20 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2025
23-12
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
30-06
Financial Weakest financial yearnet €81k ▼23.9%
Net result drops to €81k, the lowest in the series.
30-06
Financial Equity above €1MEq €1.04M ▲8.4%
7 profitable years in a row build equity to €1.04M.
2024
19-12
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
15-01
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
04-01
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-06
Financial Highest result since 2019net €142k ▲33.2%
Operating result €221k, net result €142k, both a record.
25-01
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
29-01
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-06
Financial Equity above €500kEq €550k ▲16.9%
2 profitable years in a row build equity to €550k.
2019
20-12
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
22-01
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
12-12
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
17-01
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zemst · 1 establishment unit since 1986
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Tervuursesteenweg 1981981 Zemst
Ground area
793 m²
Building footprint
376 m²
Volume, LiDAR
1,488 m³
Parcel 23034A0407/00V003, Flanders · tallest building 10.9 m. Linked by address, not a title deed.
1 establishment unit
BVBA APOTHEEK SERMEUS
Tervuursesteenweg 198, 1981 ZemstWarehousing and support activities for transportation
since 19862.035.581.721
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23034A0407/00V003 Flanders 793 m² 1 · 376 m² 10.9 m
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Zemst2.035.581.721
1 permission
Apotheek (LM>3 maand) · since 01-01-2006

Similar companies · same sector, comparable size

Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 2,982 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company (pre-2019)
Founded02-06-1986
Fiscal year end30-06
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 39 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.